P. Aitana Azurmendi

Also affiliated with Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens”.

Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens

Nature Communications(2021)10.1038/s41467-021-25605-4

N/A

0.553DataRank · unranked

39 citations

Michelle S. Miller, Puchong Thirawatananond, Jacqueline Douglass, Katharine M. Wright, Emily Han-Chung Hsiue +17 more

The rapid and highly parallel identification of antibodies with defined biological activities by SLISY

Nature Communications(2023)10.1038/s41467-022-35668-6

N/A

0.312DataRank · unranked

7 citations

Austin K. Mattox, P. Aitana Azurmendi, Ilias Christodoulou, Katharine M. Wright, Maria Popoli +11 more

Targeting a neoantigen derived from a common TP53 mutation

Science(2021)10.1126/science.abc8697

N/A

0DataRank · unranked

350 citations

Katharine M. Wright, Jacqueline Douglass, Michael S. Hwang, Brian J. Mog, Alexander H. Pearlman +20 more

Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen

Nature Communications(2023)10.1038/s41467-023-40821-w

N/A

0DataRank · unranked

25 citations

Sarah R. DiNapoli, Michelle S. Miller, P. Aitana Azurmendi, Xiaowei Zhao, Zhiheng Yu +17 more

The C-Terminal of NaV1.7 Is Ubiquitinated by NEDD4L

ACS Bio & Med Chem Au(2023)10.1021/acsbiomedchemau.3c00031

N/A

0DataRank · unranked

3 citations

Hanjie Jiang, Wendy Xia, Michael Murphy, Tatiana Boronina, Justin N. Nwafor +7 more

Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities

Science Translational Medicine(2024)10.1126/scitranslmed.adg7123

N/A

0DataRank · unranked

25 citations

Nikita Marcou, Sarah R. DiNapoli, Alexander H. Pearlman, Tushar D. Nichakawade, Michael S. Hwang +19 more